ICU Medical Inc. (NASDAQ:ICUI) – Roth Capital dropped their Q4 2017 earnings estimates for shares of ICU Medical in a report released on Thursday. Roth Capital analyst C. Lewis now expects that the brokerage will post earnings per share of $1.05 for the quarter, down from their prior estimate of $1.10.
A number of other research firms have also recently weighed in on ICUI. Piper Jaffray Cos. reaffirmed a “neutral” rating and set a $119.00 price objective (up from $115.00) on shares of ICU Medical in a research report on Thursday, August 11th. Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $141.00 price objective on the stock in a research report on Wednesday, September 21st.
Shares of ICU Medical (NASDAQ:ICUI) opened at 149.65 on Friday. The stock’s 50 day moving average price is $126.14 and its 200-day moving average price is $112.44. ICU Medical has a 1-year low of $85.56 and a 1-year high of $150.37. The stock has a market cap of $2.41 billion, a price-to-earnings ratio of 44.57 and a beta of 0.37.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Monday, August 8th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.10. The firm earned $96.70 million during the quarter, compared to analyst estimates of $89.66 million. ICU Medical had a return on equity of 10.33% and a net margin of 14.94%. The business’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.97 earnings per share.
In related news, VP Thomas D. Mccall sold 2,071 shares of the business’s stock in a transaction that occurred on Thursday, August 11th. The stock was sold at an average price of $126.07, for a total value of $261,090.97. Following the transaction, the vice president now directly owns 2,129 shares of the company’s stock, valued at approximately $268,403.03. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Richard Md Sherman sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, October 6th. The stock was sold at an average price of $140.60, for a total value of $210,900.00. Following the completion of the transaction, the director now directly owns 70,699 shares in the company, valued at $9,940,279.40. The disclosure for this sale can be found here. 15.90% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Tower Research Capital LLC TRC acquired a new position in ICU Medical during the second quarter worth approximately $124,000. Bank of Montreal Can purchased a new stake in ICU Medical during the second quarter worth about $133,000. Amalgamated Bank purchased a new stake in ICU Medical during the second quarter worth about $214,000. PineBridge Investments L.P. increased its stake in ICU Medical by 3.6% in the second quarter. PineBridge Investments L.P. now owns 1,835 shares of the company’s stock worth $207,000 after buying an additional 63 shares during the last quarter. Finally, Teacher Retirement System of Texas increased its stake in ICU Medical by 13.8% in the second quarter. Teacher Retirement System of Texas now owns 2,003 shares of the company’s stock worth $226,000 after buying an additional 243 shares during the last quarter. 89.50% of the stock is currently owned by institutional investors.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.